Tammy Lovell

DiGA
By  Tammy Lovell 12:18 pm May 5, 2021
Germany is set to enter an era of digital health over next few years, making it a significant market for health tech solutions. Digital health analysis and consultancy firm Research2Guidance (R2G) has published a white paper examining the challenges and opportunities, in light of Germany’s new digital health application (DiGA) fast track approval process. Legislative changes under the 2019...
Kry, investor, Livi
By  Tammy Lovell 09:27 am April 27, 2021
Digital healthcare company Kry, operating as Livi in the UK and France, today announced a funding round of more than $300 million to fuel its European expansion plans. The Series D funding round was led by CPP Investments (CPPIB) and Fidelity Management & Research LLC with participation from existing investors, including the Ontario Teachers’ Pension Plan (Ontario Teachers’), Index Ventures,...
OxiFlow
By  Tammy Lovell 06:52 am April 8, 2021
Origami is more traditionally associated with the art of paper folding, but one British startup is using the technique to develop a treatment for brain aneurysms. Oxford Endovascular Ltd has raised $10 million in Series A funding for its OxiFlow solution, which aims to overcome challenges with existing medical devices. Vulpes Investment Management led the round, with the Additio Investment Group...
Series B, funding, Zedsden
By  Tammy Lovell 09:51 am April 6, 2021
UK health tech startup Zedsen has announced a $12M (£8.7M) Series B round of funding at a $110 valuation. The London-based firm makes non-invasive sensors which use key biological signals from consumers’ bloodstreams to provide personalised health insights.  Investors include Joseph R Grano, former chairperson and CEO of UBS Financial Services Inc, Nasser Kazeminy, founder of NJK Holding and...
UV, cleaning robots, covid-19
By  Tammy Lovell 04:05 am April 3, 2021
Switzerland-based tech startup Uveya is conducting trials of robots which use ultraviolet light to protect airline passengers from COVID-19. Uveya tested the production version of the technology on the aircraft of Swiss regional carrier Helvetic Airways last month, in partnership with air services provider dnata. During the cleaning process, an autonomous sterilization robot emits concentrated UV...
AI, CE Mark
By  Tammy Lovell 06:45 am April 2, 2021
The EU has approved an artificial intelligence (AI) technology that can identify people at risk of a fatal heart attack, years before it strikes. The CaRi-Heart technology, developed by British Heart Foundation (BFH) spinout company Caristo Diagnostics, utilises coronary CT angiogram (CTTA) scans already performed in clinical practice.  It uses AI and deep-learning technology to produce a fat...
Health technology assessment, regulation
By  Tammy Lovell 06:03 am March 31, 2021
The European med tech industry has called for patient access to innovative technologies to be preserved under a new legislative proposal. Last week, the European Council agreed to start negotiations with the European Parliament concerning joint work on the EU Health Technology Assessment (HTA) Regulation. The Council called for the establishment of a coordination group comprising national health...
breast cancer detection
By  Tammy Lovell 06:13 am March 29, 2021
A breakthrough breast cancer diagnosis system could help clinicians understand the rationale behind artificial intelligence (AI) decisions. Researchers from Charité University Hospital in Berlin, the Berlin Institute of Technology and the University of Oslo have developed the new tissue-section analysis system for diagnosing breast cancer based on AI.   The system uses heatmaps to show what...
genomics, personalised medicine
By  Tammy Lovell 12:59 pm March 23, 2021
UK biotech firm Genomics plc is working with the NHS on a pilot study using genetic information to predict patients’ risk of heart disease.  Around 1,000 people in north-east England who attend routine GP health checks, will take part in the trial. An integrated risk tool (IRT), created by Oxford University spin-off Genomics plc, will be used to estimate each patient's risk of developing...
Series C
By  Tammy Lovell 10:19 am March 15, 2021
Ophthalmic startup EyeYon Medical announced today the completion of a $25 million in a Series C funding. The round was led by CR-CP Life Science Fund, which invests in life science companies that develop drugs, cell therapies, medical devices, and smart healthcare technology. Other participants in the round include Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and...